|
Cheryl R. Blanchard
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
24,984 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
6,432 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
12,155 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
5,017 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
13,928 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
18,068 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
36,690 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
5,000 |
0
|
-
|
|
-
|
Common Stock |
|
Cheryl R. Blanchard
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
24,761 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Magovcevic Ivana
|
Director, President and CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
463,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Magovcevic Ivana
|
Director, President and CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
370,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Magovcevic Ivana
|
Director, President and CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
282,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Magovcevic Ivana
|
Director, President and CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
43,271 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Magovcevic Ivana
|
Director, President and CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
405,494 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Magovcevic Ivana
|
Director, President and CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
210,629 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Magovcevic Ivana
|
Director, President and CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
369,351 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Magovcevic Ivana
|
Director, President and CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
222,687 |
0
|
-
|
|
-
|
Common Stock |
|
Magovcevic Ivana
|
Director, President and CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
485,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
24,310 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
13,928 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
33,875 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
18,068 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
24,073 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
5,000 |
0
|
-
|
|
-
|
Common Stock |
|
Suzanne L. Bruhn
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
6,235 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Bruce Booth
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
18,068 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Bruce Booth
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
5,000 |
0
|
-
|
|
-
|
Common Stock |
|
Bruce Booth
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
4,808,896 |
0
|
-
|
|
-
|
Common Stock |
|
Bruce Booth
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
1,027,978 |
0
|
-
|
|
-
|
Common Stock |
|
Bruce Booth
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
7,577 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Bruce Booth
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
12,155 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Bruce Booth
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
9,713 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Bruce Booth
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
13,928 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Bruce Booth
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
34,612 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Bruce Booth
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
48,393 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Mary T. Thistle
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
24,309 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Mary T. Thistle
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
12,155 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Mary T. Thistle
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
5,000 |
0
|
-
|
|
-
|
Common Stock |
|
Mary T. Thistle
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
18,068 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Mary T. Thistle
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
13,928 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Jennifer Ziolkowski
|
Director, Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
96,051 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Jennifer Ziolkowski
|
Director, Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
21,635 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Jennifer Ziolkowski
|
Director, Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
156,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Jennifer Ziolkowski
|
Director, Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
156,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Jennifer Ziolkowski
|
Director, Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
110,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Jennifer Ziolkowski
|
Director, Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
135,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Jennifer Ziolkowski
|
Director, Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
4,000 |
0
|
-
|
|
-
|
Common Stock |
|
Jennifer Ziolkowski
|
Director, Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
49,968 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Jennifer Ziolkowski
|
Director, Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
119,923 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Stefan Vitorovic
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
18,068 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Stefan Vitorovic
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
12,155 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Stefan Vitorovic
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
5,000 |
0
|
-
|
|
-
|
Common Stock |
|
Stefan Vitorovic
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
13,928 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Gerhard Koenig
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
18,029 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Gerhard Koenig
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
5,000 |
0
|
-
|
|
-
|
Common Stock |
|
Gerhard Koenig
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
12,155 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Gerhard Koenig
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
4,351 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Gerhard Koenig
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
13,928 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Gerhard Koenig
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
18,068 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Gerhard Koenig
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
36,690 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Gerhard Koenig
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
6,954 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
David L.F. Gray
|
Chief Science Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
125,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
David L.F. Gray
|
Chief Science Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
125,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
David L.F. Gray
|
Chief Science Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
267,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Samantha L. Budd Haeberlein
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
12,000 |
0
|
-
|
|
-
|
Common Stock |
|
Samantha L. Budd Haeberlein
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
5,000 |
0
|
-
|
|
-
|
Common Stock |
|
Samantha L. Budd Haeberlein
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
18,068 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Samantha L. Budd Haeberlein
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
13,928 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Samantha L. Budd Haeberlein
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
30,694 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Petra Kaufmann
|
Chief Medical Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
330,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Petra Kaufmann
|
Chief Medical Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
05 Aug 2025 |
144,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 May 2025 |
5,000 |
5,000
|
-
|
|
0
|
Common Stock |
|
Suzanne L. Bruhn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 May 2025 |
5,000 |
5,000
|
-
|
|
0
|
Common Stock |
|
Bruce Booth
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 May 2025 |
5,000 |
5,000
|
-
|
|
0
|
Common Stock |
|
Mary T. Thistle
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 May 2025 |
5,000 |
5,000
|
-
|
|
0
|
Common Stock |
|
Stefan Vitorovic
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 May 2025 |
5,000 |
5,000
|
-
|
|
0
|
Common Stock |
|
Gerhard Koenig
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 May 2025 |
5,000 |
5,000
|
-
|
|
0
|
Common Stock |
|
Samantha L. Budd Haeberlein
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
22 May 2025 |
5,000 |
17,000
|
-
|
|
0
|
Common Stock |
|
Magovcevic Ivana
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2025 |
485,000 |
485,000
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2025 |
33,875 |
33,875
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Bruce Booth
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2025 |
48,393 |
48,393
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Jennifer Ziolkowski
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2025 |
156,000 |
156,000
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
David L.F. Gray
|
Chief Science Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2025 |
125,000 |
125,000
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Petra Kaufmann
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 Mar 2025 |
144,000 |
144,000
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Ivana Magovcevic
|
Director, President and CEO |
Purchase of securities on an exchange or from another person at price $ 1.68 per share. |
19 Dec 2024 |
5,000 |
222,687
|
-
|
1.7 |
8,400
|
Common Stock |
|
Budd Haeberlein Samantha L.
|
Director |
Purchase of securities on an exchange or from another person at price $ 1.71 per share. |
19 Dec 2024 |
12,000 |
12,000
|
-
|
1.7 |
20,520
|
Common Stock |
|
Ivana Magovcevic
|
Director, President and CEO |
Purchase of securities on an exchange or from another person at price $ 1.67 per share. |
18 Dec 2024 |
5,000 |
217,687
|
-
|
1.7 |
8,350
|
Common Stock |
|
Magovcevic Ivana
|
Director, President and CEO |
Purchase of securities on an exchange or from another person at price $ 2.34 per share. |
05 Dec 2024 |
5,000 |
212,687
|
-
|
2.3 |
11,700
|
Common Stock |
|
Cheryl R. Blanchard
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Jun 2024 |
18,068 |
18,068
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Jun 2024 |
18,068 |
18,068
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Bruce Booth
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Jun 2024 |
18,068 |
18,068
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Mary T. Thistle
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Jun 2024 |
18,068 |
18,068
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Stefan Vitorovic
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Jun 2024 |
18,068 |
18,068
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Gerhard Koenig
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Jun 2024 |
18,068 |
18,068
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Samantha L. Budd Haeberlein
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
05 Jun 2024 |
18,068 |
18,068
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
5,017 |
5,017
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
5,017 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
13,928 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
6,432 |
6,432
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
6,432 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
12,155 |
12,155
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
12,155 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
13,928 |
13,928
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Magovcevic Ivana
|
Director, President and CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
370,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Magovcevic Ivana
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
282,000 |
282,000
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Magovcevic Ivana
|
Director, President and CEO |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
282,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Magovcevic Ivana
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
370,000 |
370,000
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
13,928 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
13,928 |
13,928
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
24,310 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
24,310 |
24,310
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
6,235 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
6,235 |
6,235
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Bruce Booth
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
13,928 |
13,928
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Bruce Booth
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
9,713 |
9,713
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Bruce Booth
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
9,713 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Bruce Booth
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
12,155 |
12,155
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Bruce Booth
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
12,155 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Bruce Booth
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
7,577 |
7,577
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Bruce Booth
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
7,577 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Bruce Booth
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
13,928 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Mary T. Thistle
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
12,155 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Mary T. Thistle
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
12,155 |
12,155
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Mary T. Thistle
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
13,928 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Mary T. Thistle
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
13,928 |
13,928
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Mary T. Thistle
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
24,309 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Mary T. Thistle
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
24,309 |
24,309
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Jennifer Ziolkowski
|
Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
135,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Jennifer Ziolkowski
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
135,000 |
135,000
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Jennifer Ziolkowski
|
Chief Financial Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
110,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Jennifer Ziolkowski
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
110,000 |
110,000
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Stefan Vitorovic
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
12,155 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Stefan Vitorovic
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
12,155 |
12,155
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Stefan Vitorovic
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
13,928 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Stefan Vitorovic
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
13,928 |
13,928
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Gerhard Koenig
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
12,155 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Gerhard Koenig
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
4,351 |
4,351
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Gerhard Koenig
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
4,351 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Gerhard Koenig
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
13,928 |
13,928
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Gerhard Koenig
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
13,928 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Gerhard Koenig
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
12,155 |
12,155
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Christopher Verni
|
General Counsel |
|
03 May 2024 |
85,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Christopher Verni
|
General Counsel |
|
03 May 2024 |
150,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Christopher Verni
|
General Counsel |
|
03 May 2024 |
150,000 |
150,000
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Christopher Verni
|
General Counsel |
|
03 May 2024 |
85,000 |
85,000
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
David L.F. Gray
|
Chief Science Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
267,000 |
267,000
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
David L.F. Gray
|
Chief Science Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
267,000 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Samantha L. Budd Haeberlein
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
13,928 |
13,928
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Samantha L. Budd Haeberlein
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
13,928 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Samantha L. Budd Haeberlein
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
03 May 2024 |
30,694 |
30,694
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Samantha L. Budd Haeberlein
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
03 May 2024 |
30,694 |
0
|
-
|
|
-
|
Stock Option Award (Right to Buy) |
|
Petra Kaufmann
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Mar 2024 |
330,000 |
330,000
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Magovcevic Ivana
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2024 |
463,000 |
463,000
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Jennifer Ziolkowski
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2024 |
156,000 |
156,000
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Christopher Verni
|
General Counsel |
|
01 Mar 2024 |
116,000 |
116,000
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
David L.F. Gray
|
Chief Science Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2024 |
125,000 |
125,000
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2024 |
24,761 |
24,761
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2024 |
24,073 |
24,073
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Bruce Booth
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2024 |
34,612 |
34,612
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Christopher Silber
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Aug 2023 |
330,000 |
330,000
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jun 2023 |
13,928 |
13,928
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jun 2023 |
13,928 |
13,928
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Bruce Booth
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jun 2023 |
13,928 |
13,928
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Mary T. Thistle
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jun 2023 |
13,928 |
13,928
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Stefan Vitorovic
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jun 2023 |
13,928 |
13,928
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Gerhard Koenig
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jun 2023 |
13,928 |
13,928
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Samantha L. Budd Haeberlein
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
07 Jun 2023 |
13,928 |
13,928
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Samantha L. Budd Haeberlein
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 May 2023 |
30,694 |
30,694
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Cheryl R. Blanchard
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2023 |
6,432 |
6,432
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Magovcevic Ivana
|
Director, President and CEO |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2023 |
370,000 |
370,000
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2023 |
6,235 |
6,235
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Bruce Booth
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2023 |
9,713 |
9,713
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Jennifer Ziolkowski
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2023 |
135,000 |
135,000
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Evan A. Thackaberry
|
SVP, Head of Early Development |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2023 |
65,000 |
65,000
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Christopher Verni
|
General Counsel |
|
01 Mar 2023 |
85,000 |
85,000
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
David L.F. Gray
|
Chief Science Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Feb 2023 |
267,000 |
267,000
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Suzanne L. Bruhn
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
27 Jul 2022 |
24,310 |
24,310
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Bruce Booth
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2022 |
12,155 |
12,155
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Mary T. Thistle
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2022 |
12,155 |
12,155
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Stefan Vitorovic
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2022 |
12,155 |
12,155
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Gerhard Koenig
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
09 Jun 2022 |
12,155 |
12,155
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Clay B. Thorp
|
Director |
Purchase of securities on an exchange or from another person at price $ 2.97 per share. |
16 May 2022 |
14,893 |
1,556,030
|
-
|
3.0 |
44,189
|
Common Stock |
|
Clay B. Thorp
|
Director |
Purchase of securities on an exchange or from another person at price $ 2.76 per share. |
16 May 2022 |
21,802 |
1,541,137
|
-
|
2.8 |
60,221
|
Common Stock |
|
Evan A. Thackaberry
|
SVP, Head of Early Development |
Purchase of securities on an exchange or from another person at price $ 4.00 per share. |
05 May 2022 |
1,500 |
1,500
|
-
|
4 |
6,000
|
Common Stock |
|
Jennifer Ziolkowski
|
Chief Financial Officer |
Purchase of securities on an exchange or from another person at price $ 3.77 per share. |
03 May 2022 |
4,000 |
4,000
|
-
|
3.8 |
15,098
|
Common Stock |
|
Christopher Verni
|
General Counsel |
|
03 May 2022 |
4,000 |
4,000
|
-
|
3.8 |
15,074
|
Common Stock |
|
Christopher Verni
|
General Counsel |
|
19 Apr 2022 |
150,000 |
150,000
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Mary T. Thistle
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Apr 2022 |
24,309 |
24,309
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Clay B. Thorp
|
Director |
Purchase of securities on an exchange or from another person at price $ 7.20 per share. |
28 Mar 2022 |
3,000 |
3,000
|
-
|
7.2 |
21,604
|
Common Stock |
|
Bruce Booth
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2022 |
7,577 |
7,577
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Jennifer Ziolkowski
|
Chief Financial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2022 |
110,000 |
110,000
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Evan A. Thackaberry
|
SVP, Head of Early Development |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2022 |
45,000 |
45,000
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Gerhard Koenig
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Mar 2022 |
4,351 |
4,351
|
-
|
|
-
|
Stock Option Grant (Right to Buy) |
|
Bruce Booth
|
Director |
|
11 Jan 2022 |
2,850,789 |
0
|
-
|
|
-
|
Series B Preferred Stock |
|
Bruce Booth
|
Director |
|
11 Jan 2022 |
2,831,520 |
4,273,896
|
-
|
|
-
|
Common Stock |
|
Bruce Booth
|
Director |
|
11 Jan 2022 |
1,027,978 |
1,027,978
|
-
|
|
-
|
Common Stock |
|
Bruce Booth
|
Director |
Purchase of securities on an exchange or from another person at price $ 14.00 per share. |
11 Jan 2022 |
535,000 |
4,808,896
|
-
|
14 |
7,490,000
|
Common Stock |
|
Bruce Booth
|
Director |
|
11 Jan 2022 |
7,852,374 |
0
|
-
|
|
-
|
Series A Preferred Stock |
|
Clay B. Thorp
|
Director |
|
11 Jan 2022 |
2,552,021 |
0
|
-
|
|
-
|
Series A Preferred Stock |
|
Clay B. Thorp
|
Director |
|
11 Jan 2022 |
926,506 |
0
|
-
|
|
-
|
Series B Preferred Stock |
|
Clay B. Thorp
|
Director |
Purchase of securities on an exchange or from another person at price $ 14.00 per share. |
11 Jan 2022 |
265,000 |
1,519,335
|
-
|
14 |
3,710,000
|
Common Stock |
|
Clay B. Thorp
|
Director |
|
11 Jan 2022 |
1,254,335 |
1,254,335
|
-
|
|
-
|
Common Stock |
|
Stefan Vitorovic
|
Director |
Purchase of securities on an exchange or from another person at price $ 14.00 per share. |
11 Jan 2022 |
1,671,148 |
5,004,393
|
-
|
14 |
23,396,072
|
Common Stock |
|
Stefan Vitorovic
|
Director |
|
11 Jan 2022 |
3,333,245 |
3,333,245
|
-
|
|
-
|
Common Stock |
|
Stefan Vitorovic
|
Director |
|
11 Jan 2022 |
7,684 |
7,684
|
-
|
|
-
|
Common Stock |
|
Stefan Vitorovic
|
Director |
|
11 Jan 2022 |
21,310 |
0
|
-
|
|
-
|
Series B Preferred Stock |
|
Stefan Vitorovic
|
Director |
|
11 Jan 2022 |
9,243,756 |
0
|
-
|
|
-
|
Series B Preferred Stock |
|
Stefan Vitorovic
|
Director |
Purchase of securities on an exchange or from another person at price $ 14.00 per share. |
11 Jan 2022 |
3,852 |
11,536
|
-
|
14 |
53,928
|
Common Stock |